Centerpoint Advisors, LLC Baxter International Inc Transaction History

Centerpoint Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$39.98 - $47.68 $12,033 - $14,351	-301 Reduced 27.84%	780 $36,000
Q1 2023 May 03, 2023	BUY	$37.58 - $52.57 $15,032 - $21,028	400 Added 58.74%	1,081 $44,000
Q3 2022 Oct 13, 2022	SELL	$53.86 - $66.8 $13,465 - $16,700	-250 Reduced 26.85%	681 $37,000
Q2 2022 Jul 18, 2022	BUY	$63.83 - $80.0 $15,957 - $20,000	250 Added 36.71%	931 $60,000
Q1 2022 Apr 27, 2022	BUY	$76.85 - $89.45 $52,334 - $60,915	681 New	681 $53,000
Q3 2018 Nov 08, 2018	SELL	$70.71 - $77.75 $3,323 - $3,654	-47 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$63.43 - $75.41 $2,981 - $3,544	47 New	47 $3,000

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Centerpoint Advisors, LLC with notifications on news.